Результаты поиска - Erik L. Kimble

  • Отображение 1 - 8 результаты of 8
Отмена результатов
  1. 1
    Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation

    Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation по José F. Camargo, Eric Wieder, Erik L. Kimble, Cara L. Benjamin, Despina S. Kolonias, Deukwoo Kwon, Xi Chen, Krishna V. Komanduri

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution

    Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution по Juan Pablo Alderuccio, Wei Zhao, Amrita J. Desai, Nicolas Gallastegui, Jeremy Ramdial, Erik L. Kimble, Macarena I. de la Fuente, Joseph D. Rosenblatt, Jennifer R. Chapman, Francisco Vega, Isildinha M. Reis, Izidore S. Lossos

    Опубликовано 2018
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients

    Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients по José F. Camargo, Erik L. Kimble, Rossana Rosa, Luis Shimose, Maria X. Bueno, Nikeshan Jeyakumar, Michele I. Morris, Lilian M. Abbo, Jacques Simkins, Maritza C. Alencar, Cara L. Benjamin, Eric Wieder, Antonio Jiménez, Amer Beitinjaneh, Mark Goodman, John Byrnes, Lazaros J. Lekakis, Denise Pereira, Krishna V. Komanduri

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients

    Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients по Jordan Gauthier, Emily C. Liang, Jennifer J. Huang, Erik L. Kimble, Alexandre V. Hirayama, Salvatore Fiorenza, Jenna Voutsinas, Qian Wu, Carla A. Jaeger-Ruckstuhl, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Kristina Braathen, Ryan Basom, Mazyar Shadman, Noam E. Kopmar, Ryan D. Cassaday, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up

    Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up по Andrew J. Portuguese, Jennifer J. Huang, Yein Jeon, Mahnoosh Taheri, Aya Albittar, Emily C. Liang, Alexandre V. Hirayama, Erik L. Kimble, Lorenzo Iovino, Christina Poh, Ajay K. Gopal, Mazyar Shadman, Brian G. Till, Filippo Milano, Aude G. Chapuis, Folashade Otegbeye, Ryan D. Cassaday, Ryan Basom, Qian Wu, David G. Maloney, Jordan Gauthier

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

    Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma по Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna Voutsinas, Qian Wu, Cecilia C.S. Yeung, Nicolas Gazeau, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Abigail Chutnik, Ryan D. Cassaday, Aude G. Chapuis, Damian J. Green, Hans‐Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

    Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy по Nicolas Gazeau, Emily C. Liang, Qian Wu, Jenna Voutsinas, Pere Barba, Gloria Iacoboni, Mi Kwon, Juan Luis Reguera Ortega, Lucía López‐Corral, Rafael Hernani, Valentín Ortiz‐Maldonado, Núria Martínez‐Cibrián, Antonio Pérez‐Martínez, Richard T. Maziarz, Staci Williamson, Eneida R. Nemecek, Mazyar Shadman, Andrew J. Cowan, Damian J. Green, Erik L. Kimble, Alexandre V. Hirayama, David G. Maloney, Cameron J. Turtle, Jordan Gauthier

    Опубликовано 2023
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

    Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies по Jordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama, Salvatore Fiorenza, Alyssa Sheih, Cassie Chou, Erik L. Kimble, Barbara S. Pender, Reed M. Hawkins, Aesha Vakil, Tinh-Doan Phi, Rachel N. Steinmetz, Abby W Jamieson, Merav Bar, Ryan D. Cassaday, Aude G. Chapuis, Andrew J. Cowan, Damian J. Green, Hans‐Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: